RxDoctor Payments Data

H Brent Bamberger, DO

Hand Surgery · Dayton, OHNPI 1467454447

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (54.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Skeletal Dynamics Inc at 53.9% of the total. Reporting peaked in 2021 at $39,249 and has fallen 50.3% since, to $19,516 in 2025. Among hand surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$99,523in general payments, 2019–2025

Across 200 payments — averaging $497.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Skeletal Dynamics Inc$54K
  • Synthes GmbH$27K
  • Acumed LLC$7K
  • Extremity Medical$4K
  • Stryker$2K
  • DJO, LLC$824
  • plus $5K from 29 others

What the payments were for

  • Consulting fees$6,2506%
  • Speaking & faculty fees$53,81654%
  • Grants$1,2861%
  • Travel & lodging$14,89215%
  • Food & beverage$9,97910%
  • Education$13,30113%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$99,523 in reported general payments places this provider in the 95th percentile of 88 hand surgery providers in Ohio.

See all hand surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$242,048
Medicare patients
472
Services billed
2,083

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XiaflexCollagenase Clostridium Hist.14$95,589
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen189$489
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen58$205
Doxycycline Monohydrate25$187
Promethazine Hcl161$161
Methylprednisolone22$121
Meloxicam11$37
Tramadol Hcl11$8

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Endo Pharmaceuticals Inc.Xiaflex$46$95,58914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 88 hand surgery providers in Ohio.

Other hand surgery in Dayton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →